As announced by the TIPO on March 3, 2012, the TW-Support Using the PPH Agreement (TW-SUPA) was effective on March 1, 2012 and the related official fee is NT$4,000 (about US$140). The amended regulation of the official fee was also effective as of March 1, 2012.

[ April 2012 ] >Back
Patent
 
I. The TW-Support Using The PPH Agreement (TW-SUPA) And The Related Official Fee Were Effective As Of March 1, 2012
   
  As announced by the TIPO on March 3, 2012, the TW-Support Using the PPH Agreement (TW-SUPA) was effective on March 1, 2012 and the related official fee is NT$4,000 (about US$140). The amended regulation of the official fee was also effective as of March 1, 2012.
   
  The PPH pilot program between the Taiwan Intellectual Property Office (TIPO) and the United States Patent and Trademark Office (USPTO) started on September 1, 2011. The PPH pilot program enables an applicant, whose claims are determined to be allowable/patentable in the Office of First Filing (OFF), to have the corresponding application filed in the Office of Second Filing (OSF) advanced out of turn for examination while at the same time allowing the OSF to exploit the search and examination results of the OFF. However, due to the long examination pendency at TIPO, search and examination results of applications whose OFF is TIPO could not be provided before the initiation of examination in the OSF. In other words, the making use of search and examination results of the OFF cannot be fully achieved. In order to promote international work-sharing in patent examination, and to encourage applicants to take advantage of expedited examination under the PPH pilot program, the TW-Support Using the PPH Agreement (TW-SUPA) examination pilot program has commenced on March 1, 2012.
   
  Where TIPO is the OFF of a TW application and a corresponding foreign application is later filed in the Patent Office which has a PPH agreement with TIPO, the applicant may request participation in the TW-SUPA pilot program and request the TW application be advanced out of turn for examination. TW-SUPA pilot program is expected to support patent acquisition through PPH and to promote international work-sharing by providing search and examination results of TIPO at an early stage. TW-SUPA pilot program will be carried out on a trial period of six months. TIPO will evaluate the result of this program to determine whether and how the program should be fully implemented after the trial period. TIPO may also change or terminate this program early if the volume of participation exceeds a manageable level, or for any other reason.
   
  Should you need more information, please feel free to contact us.
   
 
(Sources: TIPO News dated March 3 & 27, 2012)
   
II. The Description Of A Utility Model Application Should Contain A Sufficiently Clear And Complete Disclosure Of Contents Even Though It Was Granted Through Formality Examination
   
  According to a legal judgment made by the Intellectual Property Court (No. 93) in 2011, although a Utility Model application is granted without going through the substantive examination but through the formality examination only, it will be invalidated upon the request of a third party if the description of the Utility Model does not contain a sufficiently clear and complete disclosure of contents in the specification and drawings so as to enable person skilled in the art to understand the contents of and to practice said Utility Model.
   
  Though the patentee argued that the Utility Model at issue has been put into practice since there are lots of related products in the market, no evidence can prove that those products are made merely according to the contents of the Utility Model at issue. So, the patentee’s argument was rejected by the Intellectual Property Court.
   
  The related articles of the Patent Act are as follows:
  Article 26:
 
(The 2nd Paragraph)
The description of invention shall contain a sufficiently clear and complete disclosure of contents of the invention so as to enable person skilled in the art to understand the contents of and to practice said invention.
   
  Article 108
  The provisions of Articles 25 through 29, Articles 31 through 34, Paragraph Two of Article 35, Articles 42, Paragraph Two of Article 45, Article 50, Article 57, Articles 59 through 62, Articles 64 through 66, Paragraph Three and Paragraph Four of Article 67, Articles 68 through 71, Articles 73 through 75, Paragraphs One, Two and Four of Article 78, Articles 79 through 86, Articles 88 through 92 of this Act shall apply mutatis mutandis to the utility model patents.
   
 
(Source: TIPO News dated March 3, 2012)

 

Trademark
 
I. The New Trademark Act Will Be Enforced on July 1, 2012
   
  According to the News announced by the TIPO on March 27, 2012, the new Trademark Act will be enforced on July 1, 2012 as prescribed by the Executive Yuan. For more details about the new Trademark Act, please refer to our Newsletter issued in February 2012. We will be pleased to provide you with the related information upon receiving your request.
   
 
(Source: TIPO News published on March 27, 2012)
   
II. A Trademark Right Infringement Shall Be Deemed To Have Occurred If One Uses The Word(s) Contained In A Well-known Trademark As The Company Name  (a written judgment No.20 made by Intellectual Property Court in 2011)
   
 
 
(* The trademarks registered by the Plaintiff. )
   
  The Plaintiff claimed that the registration of the company name 統一生醫科技股份有限公司(the Chinese name of President Bioscience Co., Ltd.) violates the Trademark Act, Article 62:
  A trademark right infringement shall be deemed to have occurred where consent of trademark right holder is absent from any of the following conditions:
  1. Knowingly using a trademark identical or similar to a well-known registered trademark of  another person, or using the word(s) contained in the said well-known trademark as the company name, trade name or domain name or any other representation identifying the body or source of whose business, and hence diluting the distinctiveness or reputation of the said well-known trademark; or
   
  2. Knowingly using the word(s) contained in a registered trademark of another person as the company name, trade name or domain name or any other representation identifying the body or source of whose business, and hence causing confusion to relevant consumers of goods or services thereof.
   
  The judge of IP Court made a decision that the company name, 統一生醫科技股份有限公司(President Bioscience Co., Ltd.) should be cancelled, since it violates the Article 62 of Trademark Act because of the following reasons:
   
  1. The Plaintiff established their company early in 1967 in the business field of foodstuff industry. Their trademarks (as shown above) have become well-known ones in Taiwan and worldwide for many years. In addition to the products of foodstuff, they have gradually extended their business fields to nutriment and food supplements which have also become famous in Taiwan and worldwide in recent years. According to a Judgment made by Taiwan High Court in 2008, “統一” owned by the Plaintiff has been recognized as a well-known trademark.
     
  2. The Plaintiff established an affiliated company named 統一生命科技股份有限公司(President Life Science Co., Ltd.) in 2003 for mainly manufacturing the products of nutriment and food supplements. The defendant’s company name 統一生醫科技股份有限公司(President Bioscience Co., Ltd.) will be regarded as one of the Plaintiff’s affiliated companies by the consumers and hence dilute the distinctiveness or reputation of the said well-known trademarks. Although the defendant argued that they are manufacturing “mouth masks” which will not cause confusion to relevant consumers of goods thereof, it is not an important condition when alleging the 1st paragraph of the Article 62 of the Trademark Act.
     
  3.
Furthermore, the defendant uses 統一生醫科技股份有限公司(President Bioscience Co., Ltd.) as their company name, in which “統一” is not only the same as the Plaintiff’s well-known trademarks but also similar to the Plaintiff’s registered marks “統一生技中心”  or “統一生命科技中心”(these two marks mean “President Life Science Center”). Although the dependant argued that their products “mouth masks” would not cause confusion to relevant consumers of goods thereof, the dependant’s business field includes wholesale and retail services of medical appliances which is the same as the business field of the Plaintiff’s affiliated company 統一生命科技股份有限公司(President Life Science Co., Ltd.). So, the defendant’s company name will easily cause confusion to the related consumers to misunderstand that the products sold by the defendant come from the same source of the Plaintiff or misunderstand that the defendant is an affiliated company or licensee or franchisee of the Plaintiff.
 
     
  4. Though the defendant argued that the registration of their company name complies with the official requirement of the Company Act, the Article 18 of the Company Act only stipulates that “no company may use a corporate name which is identical with that of another company.” So, the registration of a company name will be allowed when the later one is not totally identical with other prior registered one. When the matter of an unfair competition is occurred, the disputes should be handled according to Fair Trade Act or Trademark Act. The Judge did not agree that the registration of the defendant’s company name according to the Company Act can prevent the defendant from violating other laws, so defendant’s arguments were rejected.
   
 
(Source: TIPO Newsletter issued on March 5, 2012)

 

 

JAW-HWA INTERNATIONAL PATENT & TRADEMARK & LAW OFFICES
10-1FL., NO.23, SEC.1, CHANG-AN E. RD., TAIPEI 10441, TAIWAN, R.O.C
TEL: 886-2-25310876        FAX: 886-2-25812761
http://www.jaw-hwa.com.tw    E-mail: jawhwa@jaw-hwa.com.tw